Evidence map›Paper›PMID 24312534›Full record

ArticlePloS one2013

Survival of Escherichia coli O157:H7 in soils from Jiangsu Province, China.

Taoxiang Zhang, Haizhen Wang, Laosheng Wu, Jun Lou, Jianjun Wu, Philip C Brookes, Jianming Xu

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Survival ofMicroorganisms · 2025
    Article
  3. Article
  4. Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2023
    Article
  5. Survival of EnterohemorrhagicPathogens (Basel, Switzerland) · 2021
    Article
  6. Transmission ofMicroorganisms · 2021
    Article
  7. Leptospirosis and Coinfection: Should We Be Concerned?International journal of environmental research and public health · 2021
    Review
  8. Review
  9. Variations of Escherichia coli O157:H7 Survival in Purple Soils.International journal of environmental research and public health · 2017
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Taoxiang ZhangCollege of Environmental and Natural Resource Sciences, Zhejiang Provincial Key Laboratory of Subtropical Soil and Plant Nutrition, Zhejiang University, Hangzhou, China.
Haizhen Wang
Laosheng Wu
Jun Lou
Jianjun Wu
Philip C Brookes
Jianming Xu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli O157:H7 (E. coli O157:H7) is recognized as a hazardous microorganism in the environment and for public health. The E. coli O157:H7 survival dynamics were investigated in 12 representative soils from Jiangsu Province, where the largest E. coli O157:H7 infection in China occurred. It was observed that E. coli O157:H7 declined rapidly in acidic soils (pH, 4.57 - 5.14) but slowly in neutral soils (pH, 6.51 - 7.39). The survival dynamics were well described by the Weibull model, with the calculated td value (survival time of the culturable E. coli O157:H7 needed to reach the detection limit of 100 CFU g(-1)) from 4.57 days in an acidic soil (pH, 4.57) to 34.34 days in a neutral soil (pH, 6.77). Stepwise multiple regression analysis indicated that soil pH and soil organic carbon favored E. coli O157:H7 survival, while a high initial ratio of Gram-negative bacteria phospholipid fatty acids (PLFAs) to Gram-positive bacteria PLFAs, and high content of exchangeable potassium inhibited E. coli O157:H7 survival. Principal component analysis clearly showed that the survival profiles in soils with high pH were different from those with low pH.

Indexed as

Microbial ViabilitySoilSoil MicrobiologyChinaEscherichia coli O157Hydrogen-Ion ConcentrationSoil

Identifiers

PMID24312534
PMCPMC3846838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.